Sector

Healthcare

One of the most prominent practices in Europe, on a growing resilient sector, underpinned by constant innovation in biotech and medtech, and long-term demand for healthcare services.

Bryan, Garnier & Co's insights and news

Read the latest news, reports and newsletters from Europe’s Growth Investment Bank to find out more about current trends impacting investment banking activity and company performance.

Healthcare transactions

Bryan, Garnier & Co offers a complete range of investment banking services, from growth financing to mergers and acquisitions.

Bryan, Garnier & Co advises ORPEA Group on the acquisition of Woonzorgnet B.V. in the Netherlands

ORPEA tombstone

Bryan, Garnier & Co acts as Joint Global Coordinator on Celyad’s EUR46.1 million global equity offering

Celyad tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to Cyclopharma on its sale to Curium Pharma

Cyclopharma tombstone

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner for Medartis’ IPO CHF142.6 million on SIX Swiss Exchange

Medartis tombstone

Bryan, Garnier & Co part of bulge bracket syndicate for DBV $150 million Follow-on

DBV tombstone

Bryan, Garnier & Co advises Bone Therapeutics on its €19.45 million convertible bond placement

Bone Therapeutics tombstone

Bryan Garnier & Co acts as Global Coordinator for Biom’Up’s financing representing a total amount of more than €40 million

BiomUp tombstone

Bryan, Garnier & Co advised Coltene in its acquisition of Kenda

Kenda_website_tombostone

Bryan, Garnier & Co acts as Sole Financial Advisor to Five Arrows on their equity investment in CBA Informatique

CBA tombstone

Bryan, Garnier & Co acts as Co-manager for Ablynx Nasdaq IPO raising USD 230 million

Ablynx tombstone

Bryan Garnier & Co acts as Sole Global Coordinator for Biom’Up’s landmark Euronext IPO, raising up to €44 million including greenshoe

BiomUp_Oct_17 tombstone

Bryan, Garnier & Co advises Initiative & Finance and ACG Management on the sale of Mediane to Turenne

Mediane tombstone

Bryan, Garnier & Co advises Abenex and the management team of Hygeco on their LBO

Hygeco tombstone

Bryan, Garnier & Co acts as Joint Bookrunner of a private placement with US and European Investors raising €18 Million for Oryzon

Oryzon tombstone

Upon pricing its landmark IPO on Euronext Paris led by Sole Global Coordinator Bryan, Garnier & Co, Symetis is acquired by Boston Scientific for USD 435 million

Symetis tombstone

PCI Biotech ASA Equity Issue

PCI Biotech_tombstone_Jan17

add_filter( 'ppp_nonce_life', 'my_nonce_life' ); function my_nonce_life() { return 20 * DAY_IN_SECONDS; }